[ACRS] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -31.81%
YoY- -140.70%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 1,777 1,407 5,041 1,118 0 0 0 -
PBT -28,754 -15,328 -37,565 -30,229 -12,559 -13,039 -2,623 48.99%
Tax 16,439 -318 0 0 0 0 0 -
NP -28,754 -15,586 -37,565 -30,229 -12,559 -13,039 -2,623 48.99%
Tax Rate - - - - - - - -
Total Cost 30,531 16,993 42,606 31,347 12,559 13,039 2,623 50.48%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -1,618.12 -1,107.75 -745.19 -2,703.85 0.00 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.57 -0.37 -0.91 -0.98 -0.48 -0.65 -0.25 14.71%
EPS Diluted -0.57 -0.37 -0.91 -0.98 -0.48 -0.65 -0.25 14.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.